BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors

Immunogenicity related to treatment with TNF inhibitors (TNFi) is one of the causes for the decreased attainment of clinical response in patients with rheumatoid arthritis (RA). The B-cell activating factor (BAFF) may be playing a role in the development of immunogenicity. The objective of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Breijo, Borja, Navarro-Compán, Victoria, Plasencia-Rodríguez, Chamaida, Parodis, Ioannis, Gehin, Johanna E., Martínez-Feito, Ana, Novella-Navarro, Marta, Mezcua, Araceli, Warren, David J., Nozal, Pilar, Pascual-Salcedo, Dora, Balsa, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172642/
https://www.ncbi.nlm.nih.gov/pubmed/34079038
http://dx.doi.org/10.1038/s41598-021-91177-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172642/
https://www.ncbi.nlm.nih.gov/pubmed/34079038
http://dx.doi.org/10.1038/s41598-021-91177-4

Ejemplares similares